rts logo

Cellebrite DI Ltd (CLBT) Looks Ready for Growth Despite 27.94% Change This Year

Cellebrite DI Ltd (NASDAQ: CLBT) is 27.94% higher on its value in year-to-date trading and has touched a low of $5.22 and a high of $12.50 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CLBT stock was last observed hovering at around $11.45 in the last trading session, with the day’s loss setting it -0.37%.

Currently trading at $11.08, the stock is -5.30% and 4.76% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.99 million and changing -3.23% at the moment leaves the stock 33.06% off its SMA200. CLBT registered 92.36% gain for a year compared to 6-month gain of 46.75%. The firm has a 50-day simple moving average (SMA 50) of $6.11 and a 200-day simple moving average (SMA200) of -$30.36.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -7.44% loss in the last 1 month and extending the period to 3 months gives it a 27.94%, and is -5.14% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.40% over the week and 3.36% over the month.

Cellebrite DI Ltd (CLBT) has around 1008 employees, a market worth around $2.27B and $325.11M in sales. Fwd P/E is 47.94. Profit margin for the company is -24.95%. Distance from 52-week low is 112.26% and -11.36% from its 52-week high. The company has generated returns on investments over the last 12 months (-187.00%).

Cellebrite DI Ltd quarterly earnings per share for the current quarter are estimated at $0.06 with sales reaching $85.59M over the same period.The EPS is expected to grow by 148.70% this year, but quarterly earnings will post 15.90% year-over-year. Quarterly sales are estimated to grow 20.20% in year-over-year returns.

Cellebrite DI Ltd (CLBT) Top Institutional Holders

145 institutions hold shares in Cellebrite DI Ltd (CLBT), with institutional investors hold 83.74% of the company’s shares. The shares outstanding are 203.23M, and float is at 55.50M with Short Float at 4.72%. Institutions hold 42.45% of the Float.

The top institutional shareholder in the company is True Wind Capital Management, L.P. with over 13.39 million shares valued at $96.39 million. The investor’s holdings represent 6.88% of the CLBT Shares outstanding. As of Jun 29, 2023, the second largest holder is Phoenix Holdings Ltd. with 6.35 million shares valued at $45.74 million to account for 3.26% of the shares outstanding. The other top investors are Greenhaven Road Investment Management, L.P. which holds 3.53 million shares representing 1.81% and valued at over $25.41 million, while Crosslink Capital Inc holds 1.65% of the shares totaling 3.21 million with a market value of $23.1 million.

Related Posts